Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
This test estimates how well factor II, also called prothrombin, is working in your blood. Prothrombin is a vitamin K dependent protein made by the liver that is essential for normal clot formation. A functional or activity assay looks at how effectively your factor II participates in the clotting process, rather than how much of the protein is present.
A preliminary result is often used as an initial screen. If the value is not within the expected range or if it could be affected by medicines or sample issues, your care team may order confirmatory or specialized follow-up tests to clarify the finding.
Doctors order factor II activity testing when there are signs of unusual bleeding, when other clotting tests such as the PT/INR are abnormal, or when they suspect a problem with vitamin K, liver function, or certain medications. Low factor II activity can occur in inherited factor II deficiency, but more commonly it is acquired from conditions such as vitamin K deficiency, liver disease, or treatment with vitamin K antagonists.
Understanding your factor II activity helps distinguish among different causes of bleeding or abnormal screening tests and can guide treatment decisions, such as giving vitamin K, adjusting anticoagulant therapy, or evaluating for inhibitors. High results are uncommon and usually not clinically significant, but context matters.
If your activity is lower than expected, your clinician will consider common explanations first, including medication effects, liver health, and vitamin K status. Sometimes repeat testing or a mixing study is used to decide whether the result is due to a true deficiency or an inhibitor that interferes with the assay. Your care team may also check other vitamin K dependent factors and basic liver tests to get a complete picture.
If your activity is within the expected range, it supports adequate prothrombin function at the time of testing. If it is higher than expected, it is usually not a cause for concern, but interpretation depends on your symptoms and other lab results. Always discuss next steps with your clinician, who may recommend follow-up testing or changes in medicines based on your overall clinical situation.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Warfarin and other vitamin K antagonists lower factor II activity, while direct oral anticoagulants and heparins can interfere with clot-based assays and lead to misleading results. Tell your care team about all blood thinners you take.
Underfilled citrate tubes, high hematocrit, prolonged tourniquet time, delayed processing, or improper storage can falsely alter activity. Proper collection and timely testing help ensure accurate results.
Because factor II is made in the liver and depends on vitamin K, liver disease, poor nutrition, malabsorption, or antibiotic use that reduces gut flora can lower activity. Addressing these issues can normalize results.
Rare autoantibodies can inhibit factor II or interfere with the assay, sometimes in the setting of lupus anticoagulant. Mixing studies and inhibitor testing help distinguish these causes from true deficiency.
Hormonal changes in pregnancy or estrogen therapy can shift several clotting proteins and may influence interpretation. Your clinician will interpret results in the context of pregnancy status and timing.
Transfusion of plasma or administration of prothrombin complex concentrates can temporarily change activity and may mask an underlying deficiency. Share recent treatments with your care team.
References